Difference in the distribution of tumor-infiltrating CD8+T cells and FOXP3+T cells between micronodular thymoma with lymphoid stroma and micronodular thymic carcinoma with lymphoid stroma

被引:9
|
作者
Yagi, Haruna [1 ]
Nakaguro, Masato [2 ]
Ito, Masafumi [3 ]
Okumura, Yuki [2 ]
Takahashi, Seishiro [4 ]
Aoshima, Yoichiro [1 ]
Enomoto, Yasunori [1 ]
Meguro, Shiori [1 ]
Kawasaki, Hideya [5 ]
Kosugi, Isao [1 ]
Shimoyama, Yoshie [2 ]
Ogawa, Hiroshi [4 ]
Tateyama, Hisashi [6 ]
Iwashita, Toshihide [1 ]
机构
[1] Hamamatsu Univ, Sch Med, Dept Regenerat & Infect Pathol, Hamamatsu, Shizuoka, Japan
[2] Nagoya Univ Hosp, Dept Pathol & Lab Med, Nagoya, Aichi, Japan
[3] Nagoya First Hosp, Japanese Red Cross, Dept Pathol, Nagoya, Aichi, Japan
[4] Seirei Mikatahara Hosp, Dept Diagnost Pathol, Hamamatsu, Shizuoka, Japan
[5] Hamamatsu Univ, Sch Med, Preeminent Med Photon Educ & Res Ctr, Inst NanoSuit Res, Hamamatsu, Shizuoka, Japan
[6] Kasugai Municipal Hosp, Dept Pathol, Clin Lab, Kasugai, Aichi, Japan
关键词
CD8; FOXP3; micronodular thymic carcinoma with lymphoid stroma; micronodular thymoma with lymphoid stroma; PD‐ 1; L1; thymic epithelial tumor; tumor microenvironment; tumor‐ infiltrating lymphocyte; REGULATORY T-CELLS; EPITHELIAL TUMORS; IMMUNE PRIVILEGE; EXPRESSION; PD-L1; CANCER; PROGNOSIS; CD8(+); SPECTRUM; SERIES;
D O I
10.1111/pin.13099
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Micronodular thymoma with lymphoid stroma (MNT) is a rare thymic epithelial neoplasm subtype characterized by a micronodular tumor cell growth pattern and abundant lymphoid stroma. Micronodular thymic carcinoma with lymphoid stroma (MNCA) is considered as a malignant counterpart of MNT and exhibits a growth pattern similar to that of MNT but has histologic features reminiscent of thymic squamous cell carcinoma, such as cytologic atypia and CD5 and CD117 immunoexpression. Although both MNT and MNCA are characterized by abundant lymphoid stroma, it remains unknown whether there are differences in infiltrating lymphocytes between MNT and MNCA. We analyzed the immune microenvironment profile in eight MNT and three MNCA cases. The cell density of CD8-positive T cells was significantly higher in MNT than in MNCA, whereas that of FOXP3-positive T cells was significantly higher in MNCA than in MNT. There was no significant difference in the cell density of programmed death protein 1-positive T cells and programmed death ligand 1 expression between the MNT and MNCA cases. Our findings indicated that the immune microenvironment of MNCA differed from that of MNT and, compared with the T-cell profile of MNT, that of MNCA was more suppressive to patients ' antitumor immune response.
引用
收藏
页码:453 / 462
页数:10
相关论文
共 50 条
  • [21] Inhibition of Heme Oxygenase 1 Suppresses Growth, Migration, and Invasion, and Regulates Tumor-Infiltrating CD8+T Cells and in Uveal Melanoma
    Hou, Chen
    Wan, Qi
    Xiao, Lirong
    Xiao, Qing
    Zhang, Meixia
    Yan, Naihong
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2024, 65 (10)
  • [22] Tumor-infiltrating CD8+T cells combined with tumor-associated CD68+macrophages predict postoperative prognosis and adjuvant chemotherapy benefit in resected gastric cancer
    Lu, Jun
    Xu, Yu
    Wu, Yuan
    Huang, Xiao-yan
    Xie, Jian-wei
    Wang, Jia-bin
    Lin, Jian-xian
    Li, Ping
    Zheng, Chao-hui
    Huang, Ai-min
    Huang, Chang-ming
    BMC CANCER, 2019, 19 (01)
  • [23] Analysis of FoxP3+T-Regulatory Cells and CD8+T-Cells in Ovarian Carcinoma: Location and Tumor Infiltration Patterns Are Key Prognostic Markers
    Hermans, Cecilia
    Anz, David
    Engel, Jutta
    Kirchner, Thomas
    Endres, Stefan
    Mayr, Doris
    PLOS ONE, 2014, 9 (11):
  • [24] Clinical and Prognostic Significance of Tumor-Infiltrating CD8+T Cells and PD-L1 Expression in Primary Gastrointestinal Stromal Tumors
    Sun, Xiangfei
    Shu, Ping
    Fang, Yong
    Yuan, Wei
    Zhang, Qiang
    Sun, Jianyi
    Fu, Min
    Xue, Anwei
    Gao, Xiaodong
    Shen, Kuntang
    Hou, Yingyong
    Sun, Yihong
    Qin, Jing
    Qin, Xinyu
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [25] An increase in CD4+CD25+FOXP3+ regulatory T cells in tumor-infiltrating lymphocytes of human glioblastoma multiforme
    El Andaloussi, Abdejabar
    Lesniak, Maciej S.
    NEURO-ONCOLOGY, 2006, 8 (03) : 234 - 243
  • [26] Increased tumor-infiltrating plasmacytoid dendritic cells express high levels of PD-L2 and affect CD8+T lymphocyte infiltration in human laryngeal squamous cell carcinoma
    Ji, Yangyang
    Heng, Yu
    Zhu, Xiaoke
    Zhang, Duo
    Tang, Di
    Zhou, Jian
    Lin, Hanqing
    Ma, Jingyu
    Ding, Xuping
    Tao, Lei
    Lu, Liming
    TRANSLATIONAL ONCOLOGY, 2024, 45
  • [27] Generation of highly activated, antigen-specific tumor-infiltrating CD8+T cells induced by a novel T cell-targeted immunotherapy
    Vila-Leahey, Ava
    MacKay, Alecia
    Portales-Cervantes, Liliana
    Weir, Genevieve M.
    Merkx-Jacques, Alexandra
    Stanford, Marianne M.
    ONCOIMMUNOLOGY, 2020, 9 (01):
  • [28] Distribution of Th17 cells and Foxp3-expressing T cells in tumor-infiltrating lymphocytes in patients with uterine cervical cancer
    Hou, Fei
    Li, Zhen
    Ma, Daoxin
    Zhang, Wenjing
    Zhang, Youzhong
    Zhang, Tingguo
    Kong, Beihua
    Cui, Baoxia
    CLINICA CHIMICA ACTA, 2012, 413 (23-24) : 1848 - 1854
  • [29] Association between Intratumoral CD8+T Cells with FoxP3+and CD163+Cells: A Potential Immune Intrinsic Negative Feedback Mechanism for Acquired Immune Resistance
    Fortis, Sotirios P.
    Sofopoulos, Michael
    Goulielmaki, Maria
    Arnogiannaki, Niki
    Ardavanis, Alexandros
    Perez, Sonia A.
    Gritzapis, Angelos D.
    Baxevanis, Constantin N.
    CANCERS, 2022, 14 (24)
  • [30] Tim-3 Expression on Tumor-Infiltrating PD-1+CD8+T Cells Correlates with Poor Clinical Outcome in Renal Cell Carcinoma
    Granier, Clemence
    Dariane, Charles
    Combe, Pierre
    Verkarre, Virginie
    Urien, Saik
    Badoual, Cecile
    Roussel, Helene
    Mandavit, Marion
    Ravel, Patrice
    Sibony, Mathilde
    Biard, Lucie
    Radulescu, Camelia
    Vinatier, Emeline
    Benhamouda, Nadine
    Peyromaure, Michael
    Oudard, Stephane
    Mejean, Arnaud
    Timsit, Marc-Olivier
    Gey, Alain
    Tartour, Eric
    CANCER RESEARCH, 2017, 77 (05) : 1075 - 1082